The characteristics of pre-existing humoral imprint determine efficacy of S. aureus vaccines and support alternative vaccine approaches.
第一作者:
J R,Caldera
第一单位:
Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA; Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA.
作者:
医学主题词
动物(Animals);人类(Humans);小鼠(Mice);免疫法(Immunization);耐甲氧西林金黄色葡萄球菌(Methicillin-Resistant Staphylococcus aureus);葡萄球菌菌苗(Staphylococcal Vaccines);金黄色葡萄球菌(Staphylococcus aureus);疫苗(Vaccines);临床试验(主题)(Clinical Trials as Topic)
DOI
10.1016/j.xcrm.2023.101360
PMID
38232694
发布时间
2024-10-23
基金项目
R01 AI127406/AI/NIAID NIH HHS/United States
R01 AI144694/AI/NIAID NIH HHS/United States
R01 AI179098/AI/NIAID NIH HHS/United States
R01 AI181321/AI/NIAID NIH HHS/United States
- 浏览0
Cell reports. Medicine
2024年5卷1期
101360页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



